Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(8%)
Results Posted
11%(1 trials)

Phase Distribution

Ph not_applicable
4
33%
Ph phase_4
1
8%
Ph phase_2
3
25%
Ph phase_3
3
25%

Phase Distribution

0

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
Withdrawn1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 33 (27.3%)
Phase 41 (9.1%)
N/A4 (36.4%)

Trials by Status

withdrawn18%
completed975%
recruiting18%
unknown18%

Recent Activity

1 active trials
Showing 5 of 12
completedphase_2

The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

NCT03289403
completedphase_3

Intravenous Thyroxine for Heart-Eligible Organ Donors

NCT04415658
recruitingphase_2

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

NCT06087068
completedphase_2

Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women

NCT05804149
withdrawnphase_3

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

NCT03390530
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT03289403Phase 2

The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

Completed
NCT04415658Phase 3

Intravenous Thyroxine for Heart-Eligible Organ Donors

Completed
NCT06087068Phase 2

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Recruiting
NCT05804149Phase 2

Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women

Completed
NCT03390530Phase 3

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

Withdrawn
NCT05385029

Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19

Completed
NCT03712683Not Applicable

Thyroxin in Subclinical Hypothyroidism

Completed
NCT01436994Phase 3

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

Completed
NCT02509858Not Applicable

The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus.

Completed
NCT00565890Not Applicable

Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia

Completed
NCT00715572Not Applicable

Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone

Completed
NCT00111735Phase 4

Thyroxine Titration Study

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12